As of January 22, 2025, Maravai LifeSciences (MRVI) has a market cap of $1.34 billion USD. According to our data, Maravai LifeSciences is ranked No.4754 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $1.34 B |
73.79%
|
Dec 31, 2024 | $0.77 B |
-16.79%
|
Dec 29, 2023 | $0.93 B |
-54.23%
|
Dec 30, 2022 | $2.03 B |
-65.85%
|
Dec 31, 2021 | $5.94 B |
49.38%
|
Dec 31, 2020 | $3.98 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Thermo Fisher Scientific
TMO
|
$219.73 B |
0.006 M
|
USA
|
Danaher
DHR
|
$176.31 B |
-0.004 M
|
USA
|
Bio-Rad Laboratories
BIO
|
$10.07 B |
1.804 B
|
USA
|
Agilent Technologies
A
|
$43.58 B |
0.000 M
|
USA
|
Illumina
ILMN
|
$22.26 B |
0.000 M
|
USA
|
Qiagen
QGEN
|
$10.50 B |
0.000 M
|
Netherlands
|
Charles River Laboratories
CRL
|
$8.60 B |
-0.000 M
|
USA
|
Bruker
BRKR
|
$9.11 B |
0.000 M
|
USA
|
Waters Corporation
WAT
|
$24.25 B |
0.000 M
|
USA
|
Merck
MRK
|
$242.01 B |
0.005 M
|
USA
|
Avantor
AVTR
|
$15.04 B |
-0.000 M
|
USA
|
Repligen
RGEN
|
$9.35 B |
0.000 M
|
USA
|
Market Cap | = | MRVI Stock Price | * | MRVI Shares Outstanding |
= | $5.32 | * | 0.14 B | |
= | $1.34 B |